CC
Christopher Y Chai
Chief Financial Officer

Christopher Y Chai insider trades: Principia Biopharma (PRNB) stock sales

Chief Financial Officer, Principia Biopharma Last trade Aug 18, 2020 26 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2009
3
Companies
last trade 2020

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Christopher reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 18, 2020PRNB↓ Sell$745K
May 19, 2020PRNB↓ Sell$488K
Feb 18, 2020PRNB↓ Sell$494K
Sep 20, 2011MAPP↓ Sell$492K
Sep 20, 2010MAPP↓ Sell$225K
Jul 21, 2010MAPP↓ Sell$203K
May 20, 2010MAPP↓ Sell$236K
Mar 24, 2010MAPP↓ Sell$266K
Nov 2, 2009MAPP↓ Sell$81K
Oct 1, 2009MAPP↓ Sell$103K
Feb 9, 2009MAPP↓ Sell$273

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Christopher Y Chai's insider trades

Christopher Y Chai is Chief Financial Officer at Principia Biopharma (PRNB). Since Feb 9, 2009, Christopher has reported no open-market purchases and 11 sales worth $3.3M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (13 filings), grants and awards (12 filings), shares returned to the company (2 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PRNB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.